S&P revises Express Scripts watch to positive

S&P said it revised its CreditWatch implications on its ratings on Express Scripts Holding Co., including the BBB+ issuer credit rating and BBB+ issue-level rating on the company's unsecured debt, to positive from developing.

The ratings were originally placed on CreditWatch with developing implications on March 8, 2018, following Cigna's announcement that it was acquiring Express Scripts.

Both Cigna and Express Scripts have obtained shareholders' approval for the acquisition. However, the transaction remains subject to regulatory approval.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.